timeline therapies for non small cell lung cancer

timeline therapies

1. Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries   Vincent D. de Jager, Wim Timens, Arnaud Bayle, Johan Botling, Luka Brcic, Reinhard Büttner, Maria Gabriela O. Fernandes, Libor Havel, Maximilian J. Hochmair, Paul Hofman, Annelies Janssens, Mikael Johansson, Léon van Kempen, Izidor Kern, Fernando Lopez-Rios, Margreet Lüchtenborg, José Carlos Machado, Katja Mohorcic, Luis Paz-Ares, Sanjay Popat, Aleš Ryška, Phillipe Taniere, Jürgen Wolf, Ed Schuuring, Anthonie J. van der Wekken   The Lancet Regional Health – Europe   Volume 38 (March 2024) DOI: 10.1016/j.lanepe.2024.100838 Copyright © 2024 The Authors Terms and Conditions

2. Fig. 1 The Lancet Regional Health – Europe  2024 38DOI: (10.1016/j.lanepe.2024.100838) Copyright © 2024 The Authors Terms and Conditions

3. Fig. 2 The Lancet Regional Health – Europe  2024 38DOI: (10.1016/j.lanepe.2024.100838) Copyright © 2024 The Authors Terms and Conditions